These results underscore the drugs efficacy in improving liver health
GLP-1s, such as exenatide and liraglutide, enhance the activity of GLP-1 receptors, thereby stimulating insulin secretion, suppressing glucagon release, and slowing down the emptying of the stomach
In the first month, you may notice less appetite, fewer cravings, and sometimes mild nausea
CDC , Centers for Disease Control National Diabetes Statistics Report (Diabetes, 2024), [Google Scholar] 4
Clinicians can review broader guidance on GLP-1 receptor agonists through the American Diabetes Association at diabetes.org
These mutations impair the structure and function of cilia, leading to diverse and often severe phenotypic manifestations